Indication
Renal Cell Cancer Metastatic
3 clinical trials
3 products
1 drug
Clinical trial
An Open-Label, Phase 1/2 Study to Evaluate Safety, Efficacy, and Pharmacokinetics of EU101, an Agonistic Anti-CD137 (4-1BB) Monoclonal Antibody in Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2025-09-01
Product
EU101Clinical trial
A Phase 2 Trial of PT2977 in Combination With Cabozantinib in Patients With Advanced Clear Cell Renal Cell CarcinomaStatus: Active (not recruiting), Estimated PCD: 2025-08-31
Product
BelzutifanProduct
CabozantinibClinical trial
A Phase II Trial of Intrapleural Instillation of the Nivolumab in Cancer Patients With Pleural Effusion.Status: Completed, Estimated PCD: 2023-03-01
Drug
T-VEC